The production of these vectors has been a focus of recent research, as scientists strive to improve the efficiency, scalability, and quality of lentiviral vector manufacturing processes.

Although lentiviral vector production techniques have matured in recent years with companies such as OriGene Technologies now offering an array of lentiviral vectors and particles to address ...

The production of a lentivirus begins with cloning the gene of interest (goi ... Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with ...

Oxford, UK – 5 February 2025: OXB (LSE: OXB), a quality and innovation-led cell and gene therapy CDMO, today announces the appointment of Jefferies International Limited ("Jefferies") as its Joint ...

VectorBuilder's partner, Ucello, announced that its CD19-targeting umbilical cord blood-derived allogeneic CAR-T cell therapy ...

Scientists at CSCR developed a method to restore Factor VIII production using a lentiviral vector, a safe and effective alternative to the commonly used AAV vectors. A lentiviral vector is a tool ...